2021년 가축 및 축산물 BreakPoints
Antimicrobial |
Antimicrobial Agents |
Range tested |
Breakpoints |
Reference |
Aminoglycosides |
Gentamicin (GEN) |
1-64 |
≥161) |
CLSI |
Streptomycin (STR) |
16-128 |
≥322) |
NARMS |
|
Aminopenicillin |
Ampicillin (AMP) |
2-64 |
≥322) |
CLSI |
β-lactam/β-lactamase |
Amoxicillin/ |
2/1-32/16 |
≥32/162) |
CLSI |
Cephamycin |
Cefoxitin (FOX) |
1-32 |
≥321) |
CLSI |
Cephalosporin Ⅲ |
Ceftiofur (XNL) |
0.5-8 |
≥82) |
NARMS |
Ceftazidime (CAZ) |
1-16 |
≥161) |
CLSI |
|
Cephalosporin IV |
Cefepime (FEP) |
0.25-16 |
≥161) |
CLSI |
Carbapenem |
Meropenem (MEM) |
0.25-4 |
≥41) |
CLSI |
Fluoroquinolone |
0.12-16 |
≥41) |
CLSI |
|
Folate pathway inhibitors |
Trimethoprim/ |
0.12/2.38-4/76 |
≥4/761) |
CLSI |
Sulfisoxazole (FIS) |
16-256 |
≥5121) |
CLSI |
|
Phenicols |
Chloramphenicol (CHL) |
2 - 64 |
≥321) |
CLSI |
Polymyxins |
Colistin (CL) |
2-16 |
≥41) |
EUCAST |
Quinolone |
Nalidixic acid (NAL) |
2 - 128 |
≥321) |
CLSI |
Polymyxins |
Tetracycline (TET) |
2 - 128 |
≥161) |
CLSI |
1) Clinical Laboratory Standards Institute, M100S, 2021
2) National Antimicrobial Resistance Monitoring System, 2014
3) European Committee on Antimicrobial Susceptibility Testing, 2018
Antimicrobial |
Antimicrobial Agents |
Range tested |
Breakpoints |
Reference |
Aminoglycosides |
Gentamicin (GEN) |
128-2,048 |
≥1,0242) |
NARMS |
Kanamycin (KMAN) |
128-2,048 |
≥1,0242) |
NARMS |
|
Streptomycin (STR) |
128-2,048 |
≥1,0242) |
NARMS |
|
Aminopenicillin |
Ampicillin (AMP) |
1-16 |
≥161) |
CLSI |
Fluoroquinolone |
Ciprofloxacin (CIP) |
0.25-16 |
≥41) |
CLSI |
Glycopeptide |
Vancomycin (VAN) |
2-32 |
≥321) |
CLSI |
Glycylcyclines |
Tigecycline (TGC) |
0.12-4 |
≥0.53) |
DANMAP |
Lipopeptides |
Daptomycin (DAP) |
1-32 |
≥81) |
CLSI |
Macrolides |
Erythromycin (ERY) |
1-64 |
≥81) |
CLSI |
Tylosin (TYL) |
1-6 |
≥321) |
DANMAP |
|
Oxazolidinones |
Linezolid (LNZ) |
1-16 |
≥81) |
CLSI |
Phenicols |
Chloramphenicol (CHL) |
2-32 |
≥321) |
CLSI |
Florfenicol (FFC) |
2-32 |
≥164) |
DANMAP |
|
Streptogramins |
Quinupristin |
1-32 |
≥41) |
CLSI |
Tetracyclines |
Tetracycline (TET) |
2-128 |
≥161) |
CLSI |
Others |
Salinomycin (SAL) |
2-32 |
≥85) |
DANMAP |
1) Clinical Laboratory Standards Institute, M100, 2021
2) National Antimicrobial Resistance Monitoring System, 2013
3) The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme, 2016
4) The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme, 2007
5) The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme, 2013